/Companies

Attune Pharmaceuticals

New York, US · Founded 2018 · Delaware corporation · 1 known investors

Find your way into Attune Pharmaceuticals

Sign up to see every warm intro you have to Attune Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Attune Pharmaceuticals team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AT
Adam TomasiNamed on SEC filing
AM
Andrew McDonaldNamed on SEC filing
JB
Jason BablakNamed on SEC filing

Board

RW
Roderick WongBoard directorManaging Partner, CIO at RTW Investments L.P.

Investors · 1

Reported raises · per SEC filings

Form D private placements

$23.3M disclosed across 1 round · 2018

▶$23.3MraisedJun 2018 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam TomasiDirector
  • Roderick WongDirector
  • Andrew McDonaldExecutive Officer, Director
  • Jason BablakExecutive Officer
Offering amount
$23.6M
Amount sold
$23.3M
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Attune Pharmaceuticals's investors?
Attune Pharmaceuticals's investors include RTW Investments L.P..
How much funding has Attune Pharmaceuticals raised?
Attune Pharmaceuticals has disclosed $23.3M raised across 1 round.
Where is Attune Pharmaceuticals headquartered?
Attune Pharmaceuticals is headquartered in New York, US.